Benjamin F. Edwards & Company Inc. increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 8.4% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,366 shares of the medical instruments supplier’s stock after buying an additional 106 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in West Pharmaceutical Services were worth $450,000 as of its most recent filing with the SEC.
Several other hedge funds have also added to or reduced their stakes in WST. Hsbc Holdings PLC increased its position in West Pharmaceutical Services by 11.7% in the second quarter. Hsbc Holdings PLC now owns 186,718 shares of the medical instruments supplier’s stock worth $61,727,000 after buying an additional 19,561 shares during the last quarter. Blair William & Co. IL grew its stake in shares of West Pharmaceutical Services by 10.5% during the 2nd quarter. Blair William & Co. IL now owns 112,520 shares of the medical instruments supplier’s stock worth $37,063,000 after acquiring an additional 10,654 shares during the period. Meiji Yasuda Asset Management Co Ltd. increased its holdings in West Pharmaceutical Services by 3.4% in the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 8,507 shares of the medical instruments supplier’s stock worth $2,802,000 after acquiring an additional 278 shares during the last quarter. Sargent Investment Group LLC bought a new stake in West Pharmaceutical Services in the 2nd quarter valued at about $237,000. Finally, Dimensional Fund Advisors LP lifted its holdings in West Pharmaceutical Services by 11.7% during the second quarter. Dimensional Fund Advisors LP now owns 288,639 shares of the medical instruments supplier’s stock valued at $95,075,000 after purchasing an additional 30,253 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.
West Pharmaceutical Services Price Performance
Shares of NYSE:WST opened at $309.85 on Wednesday. The company has a 50-day moving average price of $302.72 and a two-hundred day moving average price of $336.46. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $22.57 billion, a PE ratio of 40.88, a P/E/G ratio of 10.58 and a beta of 1.01.
Insider Activity at West Pharmaceutical Services
In related news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now owns 1,478 shares of the company’s stock, valued at approximately $443,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.53% of the stock is currently owned by corporate insiders.
West Pharmaceutical Services Profile
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Articles
- Five stocks we like better than West Pharmaceutical Services
- There Are Different Types of Stock To Invest In
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Free Report).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.